PMC:7247521 / 46971-47237 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"850","span":{"begin":31,"end":35},"obj":"Disease"},{"id":"851","span":{"begin":81,"end":89},"obj":"Disease"},{"id":"852","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"853","span":{"begin":160,"end":168},"obj":"Disease"}],"attributes":[{"id":"A850","pred":"tao:has_database_id","subj":"850","obj":"MESH:D045169"},{"id":"A851","pred":"tao:has_database_id","subj":"851","obj":"MESH:C000657245"},{"id":"A852","pred":"tao:has_database_id","subj":"852","obj":"MESH:C000657245"},{"id":"A853","pred":"tao:has_database_id","subj":"853","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T726","span":{"begin":31,"end":35},"obj":"SP_10"},{"id":"T727","span":{"begin":81,"end":89},"obj":"SP_7"},{"id":"T728","span":{"begin":111,"end":119},"obj":"SP_7"},{"id":"T729","span":{"begin":160,"end":168},"obj":"SP_7"}],"text":"And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T191","span":{"begin":128,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A191","pred":"fma_id","subj":"T191","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T118","span":{"begin":31,"end":35},"obj":"Disease"},{"id":"T119","span":{"begin":81,"end":89},"obj":"Disease"},{"id":"T120","span":{"begin":111,"end":119},"obj":"Disease"},{"id":"T121","span":{"begin":160,"end":168},"obj":"Disease"}],"attributes":[{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage."}

{"project":"LitCovid-sentences","denotations":[{"id":"T345","span":{"begin":0,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage."}